First-in-Human Phase I Study of B-Cell Maturation-Targeted Chimeric Antigen Receptor T Cells in Advanced MM


First-in-Human Phase I Study of B-Cell Maturation-Targeted Chimeric Antigen Receptor T Cells in Advanced MM
Slides from a presentation at ASH 2015 and transcribed comments from a recent interview with Noopur Raje, MD (2/10/16)
Ali SA et al. Remissions of multiple myeloma during a first-in-humans clinical trial of T cells expressing an anti-B-cell maturation antigen chimeric antigen receptor. Proc ASH 2015;Abstract LBA-1.

Dr Raje is Director of the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center and Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts.